VIM and cancer: Although these findings could reveal the molecular mechanism of PIAS1-mediated VIM SUMOylation and its involvement in cancer cell aggressiveness, additional evidence is required to further understand the function of PIAS1-mediated SUMOylation on the other cytoskeletal proteins and how these cytoskeletal proteins collaborate during cell migration.